acc00201 |
"Actin, alpha skeletal muscle" |
oxidation |
Met48 |
human |
Colon cancer |
RW480 |
Cerulenin |
Positive |
5.0 |
PXD023569
|
acc00202 |
"Actin, alpha skeletal muscle, intermediate form" |
oxidation |
Met49 |
human |
Colon cancer |
RW480 |
Cerulenin |
Positive |
5.0 |
PXD023569
|
acc00203 |
"Actin, alpha cardiac muscle 1" |
oxidation |
Met48 |
human |
Colon cancer |
RW480 |
Cerulenin |
Positive |
5.0 |
PXD023569
|
acc00204 |
Heat shock protein HSP 90-beta |
phosphorylation |
Ser255 |
human |
Colon cancer |
RW480 |
Cerulenin |
Negative |
5.0 |
PXD023569
|
acc00205 |
Putative heat shock protein HSP 90-beta 2 |
phosphorylation |
Ser177 |
human |
Colon cancer |
RW480 |
Cerulenin |
Negative |
5.0 |
PXD023569
|
acc00206 |
Bcl-2-associated transcription factor 1 |
phosphorylation |
Ser177 |
human |
Colon cancer |
RW480 |
Cerulenin |
Positive |
5.0 |
PXD023569
|
acc00207 |
Serine/arginine repetitive matrix protein 2 |
phosphorylation |
Ser2581 |
human |
Colon cancer |
RW480 |
Cerulenin |
Negative |
5.0 |
PXD023569
|
acc00208 |
Epidermal growth factor receptor |
oxidation |
Met987 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00209 |
Annexin A2 |
oxidation |
Met240 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00210 |
Putative annexin A2-like protein |
oxidation |
Met240 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00211 |
Hepatocyte growth factor receptor |
oxidation |
Met1229 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00212 |
Hepatocyte growth factor receptor |
oxidation |
Met995 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00213 |
Transgelin-2 |
oxidation |
Met194 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00214 |
Transgelin-3 |
oxidation |
Met194 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00215 |
Amyloid beta precursor like protein 2 |
oxidation |
Met745 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00216 |
Neuroblast differentiation-associated protein AHNAK |
oxidation |
Met1465 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00217 |
Unconventional myosin-Ie |
oxidation |
Met992 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00218 |
Mitogen-activated protein kinase 14 |
oxidation |
Met179 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00219 |
RuvB-like 2 |
oxidation |
Met218 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00220 |
Insulin receptor substrate 2 |
oxidation |
Met743 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00221 |
Annexin A2 |
oxidation |
Met240 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00222 |
Putative annexin A2-like protein |
oxidation |
Met240 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00223 |
Tyrosine-protein phosphatase non-receptor type 6 |
oxidation |
Met545 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00224 |
Transgelin-2 |
oxidation |
Met194 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00225 |
Transgelin-3 |
oxidation |
Met194 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00226 |
Tyrosine-protein phosphatase non-receptor type 11 |
oxidation |
Met586 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00227 |
Amyloid beta precursor like protein 2 |
oxidation |
Met745 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00228 |
Mitogen-activated protein kinase 14 |
oxidation |
Met179 |
human |
Lung cancer |
CUTO28 |
Entrectinib |
Negative |
5.0 |
PXD031346
|
acc00229 |
Catenin delta-1 |
phosphorylation |
Ser230 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00230 |
Myelin protein zero-like protein 1 |
phosphorylation |
Ser260 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00231 |
"Keratin, type I cytoskeletal 18" |
phosphorylation |
Ser10 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00232 |
Hepatocyte growth factor receptor |
phosphorylation |
Ser1236 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00233 |
Uncharacterized protein C6orf132 |
phosphorylation |
Ser1011 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00234 |
Phostensin |
phosphorylation |
Ser224 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00235 |
Rho GTPase-activating protein 12 |
phosphorylation |
Ser240 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00236 |
Partitioning defective 3 homolog |
phosphorylation |
Ser201 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00237 |
Plakophilin-2 |
phosphorylation |
Ser135 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00238 |
Band 4.1-like protein 1 |
phosphorylation |
Ser870 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00239 |
Tight junction protein ZO-2 |
phosphorylation |
Ser244 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00240 |
Plakophilin-3 |
phosphorylation |
Ser180 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00241 |
Plakophilin-3 |
phosphorylation |
Ser92 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00242 |
Catenin delta-1 |
phosphorylation |
Thr906 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00243 |
Cyclin-dependent kinase 1 |
phosphorylation |
Thr14 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Positive |
5.0 |
PXD031346
|
acc00244 |
Amyloid beta precursor like protein 2 |
phosphorylation |
Thr754 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00245 |
Mitogen-activated protein kinase 14 |
phosphorylation |
Thr180 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00246 |
Rho GTPase-activating protein 12 |
phosphorylation |
Thr231 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00247 |
Splicing regulator ARVCF |
phosphorylation |
Tyr201 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00248 |
Claudin-4 |
phosphorylation |
Tyr208 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00249 |
Band 4.1-like protein 2 |
phosphorylation |
Tyr623 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|
acc00250 |
cAMP-regulated phosphoprotein 19 |
phosphorylation |
Tyr59 |
human |
Lung cancer |
CUTO28 |
Cabozantinib |
Negative |
5.0 |
PXD031346
|